Screener
Sionna Therapeutics SION Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Sionna Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrentAndNoncurrent.
The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033876
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Total assets | $305,039 | $325,953 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $2,109 | $769 |
| Accrued expenses | 6,328 | 9,668 |
| Operating lease liability, current | 1,322 | 1,269 |
| Other current liabilities | 17 | 6 |
| Total current liabilities | 9,776 | 11,712 |
Item 1. Financial Statements
FAQ
- What is Sionna Therapeutics's accounts payable?
- Sionna Therapeutics (SION) reported accounts payable of $2.11M in Q1 2026.
- How has Sionna Therapeutics's accounts payable changed year-over-year?
- Sionna Therapeutics's accounts payable decreased by 58.0% year-over-year, from $5.02M to $2.11M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Sionna Therapeutics's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude